Amgen Inc.
Long

return to structure with multiple confluences

46
some divergences as well as return to narrative strong point , volume profile helps check out upside story

Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.